Lifestyle interventions, particularly resistance exercise with adequate protein intake, have shown promise for preserving muscle during weight loss interventions and following discontinuation [19,20], but their effectiveness with GLP-1 RA therapies and in older adults either during or following cessation of treatment remains unclear
aging/obesity associated with blunted GH release
GLP-1 agonists commonly cause nausea, vomiting, and gastrointestinal distress, particularly during dose escalation
If you notice sudden vision changes, blurriness that doesnt resolve, or dark spots in your vision, contact your eye doctor and diabetes care provider
From this perspective, BPC-157 is not primarily a treatment for acute injury but a tool for restoring the cellular and tissue repair machinery that degrades with age
I have PPMS diagnosed 5years ago, And presently taking mounjaro 7.5 mg injections, What are the benefits of this versus ozempic